SAN DIEGO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in defense, national security, and global markets, announced today the grand opening of its new 55,000-square-foot state-of-the-art hypersonic and “Other” system manufacturing and payload integration facility in Princess Anne, Maryland. The advanced facility will significantly enhance Kratos' capabilities to support launch operations and hypersonic testing for the Multi-Service Advanced Capability Hypersonics Test Bed (MACH-TB) 2.0 program and other customers from agencies including the U.S. Navy, US Air Force, DARPA, and the Missile Defense Agency.

image for news Kratos Opens New 55,000-Square-Foot State-of-the-Art Hypersonic System Manufacturing and Payload Integration Facility in Princess Anne, Maryland

NEUHAUSEN, Switzerland--(BUSINESS WIRE)--Sensormatic Solutions, the leading global retail solutions portfolio of Johnson Controls (NYSE: JCI), today announced a new technology collaboration that can redefine inventory accuracy and management. Retailers using Sensormatic Solutions TrueVUE Cloud inventory intelligence platform can gain better visibility by connecting with Keonn Technologies' AdvanTrack-600™ real time location system. This integration can help provide a clearer view of product loc.

image for news Sensormatic Solutions and Keonn Collaboration Supports the Automation of Inventory Counts to Help Workflows, Increase Visibility and Ease Friction

NEW YORK--(BUSINESS WIRE)--MediaCo Holding Inc. (Nasdaq: MDIA), a leading multi-platform media company serving multicultural audiences nationwide, today announced a series of strategic leadership promotions across its sales, marketing, research, and revenue operations organizations. These promotions recognize exceptional performance, sustained impact, and the continued strengthening of MediaCo's commercial and operational leadership bench. “These leaders have each made a meaningful impact on ou.

image for news MediaCo Announces Key Leadership Promotions Across Sales, Marketing, Research and Operations

BioCryst Pharmaceuticals, Inc. (BCRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

image for news BioCryst Pharmaceuticals, Inc. (BCRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Summit Therapeutics Inc. (SMMT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

image for news Summit Therapeutics Inc. (SMMT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Pacific Biosciences of California, Inc. (PACB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

image for news Pacific Biosciences of California, Inc. (PACB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Guests are invited to experience two designer-decorated model homes and enjoy complimentary refreshments at the grand opening event on January 17 Guests are invited to experience two designer-decorated model homes and enjoy complimentary refreshments at the grand opening event on January 17

image for news Toll Brothers Announces Model Home Grand Opening at Woodinville Square in Woodinville, Washington

SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Skye Bioscience, Inc. (NASDAQ: SKYE) securities between November 4, 2024 and October 3, 2025, inclusive (the “Class Period”). The lawsuit seeks to recover losses for investors under the federal securities laws.

image for news Skye Bioscience, Inc. (NASDAQ: SKYE) Securities Class Action: Johnson Fistel Reminds Investors of January 16 Deadline to Seek Lead Plaintiff Appointment

SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Ardent Health, Inc. (NYSE: ARDT) securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”). The lawsuit seeks to recover losses for investors under the federal securities laws.

image for news ARDT Investors Encouraged to Seek Lead Plaintiff Role in Ardent Health, Inc. Securities Class Action with Johnson Fistel

Nvidia to Invest $1 Billion in AI Drug Lab With Eli Lilly — Positive

LLY  NVDA   Bloomberg Technology — January 12, 2026

Nvidia plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., in an effort to speed up the use of AI in the pharmaceutical industry. Denny Fish, portfolio manager on the Global Technology and Innovation Team at Janus Henderson Investors, joins Caroline Hyde and Ed Ludlow on “Bloomberg Tech.

image for news Nvidia to Invest $1 Billion in AI Drug Lab With Eli Lilly

SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether Coupang, Inc. (NYSE: CPNG) or certain of its officers and directors violated federal securities laws by making false or misleading statements and/or failing to disclose material information to investors.

image for news Coupang, Inc. (NYSE: CPNG): Johnson Fistel Investigates Data Breach Disclosures Following Multiple Stock Drops

SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Blue Owl Capital Inc. (NYSE: OWL) securities between February 6, 2025 and November 16, 2025, inclusive (the “Class Period”). The lawsuit seeks to recover losses for investors under the federal securities laws.

image for news OWL Investors Encouraged to Seek Lead Plaintiff Role in Blue Owl Capital Inc. Securities Fraud Case with Johnson Fistel

SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired DeFi Technologies Inc. (NASDAQ: DEFT) securities between May 12, 2025 and November 14, 2025, inclusive (the “Class Period”). The lawsuit seeks to recover losses for investors under the federal securities laws.

image for news DEFT Investors Encouraged to Seek Lead Plaintiff Role in DeFi Technologies Securities Fraud Case with Johnson Fistel

SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether StubHub Holdings, Inc. (NYSE: STUB) or certain of its officers and directors violated federal securities laws by making false or misleading statements and/or failing to disclose material information to investors.

image for news StubHub Holdings, Inc. (NYSE: STUB): Johnson Fistel Investigates Post-IPO Earnings Results Following Significant Stock Drop

Gilead Sciences, Inc. (GILD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

image for news Gilead Sciences, Inc. (GILD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Ascendis Pharma A/S (ASND) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

image for news Ascendis Pharma A/S (ASND) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Cytokinetics, Incorporated (CYTK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

image for news Cytokinetics, Incorporated (CYTK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Bristol-Myers Squibb Company (BMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

image for news Bristol-Myers Squibb Company (BMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

PriceSmart's Base-Case Calls for $45 in Upside—Bull-Case Is Better — Positive

PSMT   MarketBeat — January 12, 2026

PriceSmart's NASDAQ: PSMT stock price action cleared a significant hurdle in 2025, crossing to new all-time highs early in the year. The move signals a base case for $45 upside: the market broke out of a $45 trading range and later confirmed prior resistance (the top of the range) as its new support level.

image for news PriceSmart's Base-Case Calls for $45 in Upside—Bull-Case Is Better

CRISPR Therapeutics AG (CRSP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

image for news CRISPR Therapeutics AG (CRSP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript